InMed Provides Update on BayMedica Commercial Business
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug
Contango ORE (NYSEAMERICAN:CTGO) and Dolly Varden Silver (TSXV:DV) have agreed to merge in an all-stock deal that would create a new mid-tier
The Bank of Canada Governing Council met on Wednesday (December 10) for the final rate-setting meeting of 2025 and decided to hold
We also break down next week’s catalysts to watch to help you prepare for the week ahead.
House Republicans have released a 111-page plan for reforming healthcare that they hope to vote on next week. House GOP leadership aides also
President Donald Trump is being sued by a historic preservation group seeking to stop construction of his new White House ballroom. The National
The White House accused Democrats from the House Committee on Oversight and Government Reform of spreading a ‘cherry-picked’ and ‘false narrative’ Friday
United States Ambassador to the United Nations Michael Waltz recently returned from a Middle East swing, touting the ‘amazing progress’ in the